St. Jude Medical Inc. (STJ)
-NYSE 45.70 
1.08(2.31%) May 22, 4:03PM EDT|After Hours
:
46.25 0.55 (1.19%) May 22, 6:22PM EDT
| Prev Close: | 46.78 |
|---|
| Open: | 46.80 |
|---|
| Bid: | 45.41 x 300 |
|---|
| Ask: | 45.96 x 200 |
|---|
| 1y Target Est: | 45.06 |
|---|
| Beta: | 1.3 |
|---|
| Next Earnings Date: | 15-Jul-13 |
|---|
| Day's Range: | 45.43 - 47.45 |
|---|
| 52wk Range: | 30.25 - 47.45 |
|---|
| Volume: | 2,823,071 |
|---|
| Avg Vol (3m): | 2,450,070 |
|---|
| Market Cap: | 12.95B |
|---|
| P/E (ttm): | 18.38 |
|---|
| EPS (ttm): | 2.49 |
|---|
| Div & Yield: | 1.00 (2.10%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Medtronic Still Reporting Weak Growth, But A Relatively Rare Bargainat Investopedia(Wed, May 22)
- Medtronic Beats Earnings, Results StrongerZacks(Wed, May 22)
- What's Behind Medtronic's 5% Pop?at Motley Fool(Tue, May 21)
- Athletes With Defibrillators Don't Need To Quit Sportsat Forbes(Tue, May 21)
- St Jude Medical Reaches New 52-Week High (STJ)at TheStreet(Tue, May 21)
- InPlay: St. Jude Medical announces the start of its landmark EnligHTNment clinical studyBriefing.com(Tue, May 21)
- St. Jude Medical EnligHTNment Study Highlighted at EuroPCR During Trials That May Change Clinical Practice SessionBusiness Wire(Tue, May 21)
- Medtronic’s Heart Rhythm Devices Show Signs of Growthat Bloomberg(Tue, May 21)
- St. Jude Medical to Present at the 38th Annual Deutsche Bank Health Care ConferenceBusiness Wire(Tue, May 21)
- Will Obamacare Crush Medtronic's Earnings?at Motley Fool(Mon, May 20)
- Why This Big Buyback Isn't a Long-Term Solutionat Motley Fool(Fri, May 17)
- CE Mark for STJ's ILUMIEN OPTISZacks(Fri, May 17)
- St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent PlacementBusiness Wire(Thu, May 16)
- Today's 3 Best Stocksat Motley Fool(Wed, May 15)
- Health Services Stocks On The Rise With Help From 5 Stocksat TheStreet(Wed, May 15)
Key Statistics
| Forward P/E (1 yr): | 11.63 |
|---|
| P/S (ttm): | 2.43 |
|---|
| Ex-Dividend Date: | 26-Jun-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.70 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.94 |
|---|
| Mean Recommendation*: | 2.6 |
|---|
| PEG Ratio (5 yr expected): | 1.32 |
|---|
Business Summary
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in two divisions, Cardiovascular and Ablation Technologies, and Implantable Electronic Systems.
View More